PolyPeptide Group AG

SIX:PPGN.SW

32.9 (CHF) • At close November 4, 2024
Bedrijfsnaam PolyPeptide Group AG
Symbool PPGN.SW
Munteenheid CHF
Prijs 32.9
Beurswaarde 1,085,160,999
Dividendpercentage 0%
52-weken bereik 14.11 - 35.8
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Juan Jose Gonzalez
Website https://www.polypeptide.com

An error occurred while fetching data.

Over PolyPeptide Group AG

PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide

Vergelijkbare Aandelen

Medacta Group SA logo

Medacta Group SA

MOVE.SW

113.6 CHF

Idorsia Ltd logo

Idorsia Ltd

IDIA.SW

0.951 CHF

Siegfried Holding AG logo

Siegfried Holding AG

SFZN.SW

1,140 CHF

Ypsomed Holding AG logo

Ypsomed Holding AG

YPSN.SW

395.5 CHF

Aevis Victoria SA logo

Aevis Victoria SA

AEVS.SW

13.9 CHF

BB Biotech AG logo

BB Biotech AG

BION.SW

36.85 CHF

Medartis Holding AG logo

Medartis Holding AG

MED.SW

55.5 CHF

Galenica AG logo

Galenica AG

GALE.SW

75.4 CHF

Cosmo Pharmaceuticals N.V. logo

Cosmo Pharmaceuticals N.V.

COPN.SW

66.8 CHF

Financiële Gegevens

Cijfers zijn in miljoenen (CHF)

Cijfers zijn in miljoenen (CHF)